[HTML][HTML] Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
The cellular and molecular mechanisms of tumor angiogenesis and its prospects for anti-
angiogenic cancer therapy are major issues in almost all current concepts of both cancer …
angiogenic cancer therapy are major issues in almost all current concepts of both cancer …
[HTML][HTML] Anti-angiogenic therapies in the management of glioblastoma
JD Schulte, MK Aghi, JW Taylor - Chinese clinical oncology, 2021 - ncbi.nlm.nih.gov
Angiogenesis is a central feature of glioblastoma (GBM), with contribution from several
mechanisms and signaling pathways to produce an irregular, poorly constructed, and poorly …
mechanisms and signaling pathways to produce an irregular, poorly constructed, and poorly …
Vascular microenvironment in gliomas
P Vajkoczy, MD Menger - Journal of neuro-oncology, 2000 - Springer
Structural and functional abnormalities of the vascular microenvironment determine
pathophysiological characteristics of gliomas, such as loss of blood–brain barrier function …
pathophysiological characteristics of gliomas, such as loss of blood–brain barrier function …
Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation
S Takano - Brain tumor pathology, 2012 - Springer
Glioblastomas are highly vascular tumors. Recent preclinical and clinical investigations
have revealed that agents targeting angiogenesis may have efficacy against this type of …
have revealed that agents targeting angiogenesis may have efficacy against this type of …
Vascular microenvironment in gliomas
P Vajkoczy, MD Menger - Angiogenesis in Brain Tumors, 2004 - Springer
Structural and functional abnormalities of the vascular microenvironment determine
pathophysiological characteristics of gliomas, such as loss of blood-brain barrier function …
pathophysiological characteristics of gliomas, such as loss of blood-brain barrier function …
[HTML][HTML] Exploring the past, present, and future of anti-angiogenic therapy in glioblastoma
AB Zhang, K Mozaffari, B Aguirre, V Li, R Kubba… - Cancers, 2023 - mdpi.com
Simple Summary Glioblastoma is the most common malignant primary brain tumor. Despite
technological advancements and modern therapeutic agents used for treatment, the …
technological advancements and modern therapeutic agents used for treatment, the …
Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma
R Rahman, S Smith, C Rahman… - Journal of Oncology, 2010 - Wiley Online Library
Despite advances in surgery, radiation therapy, and chemotherapeutics, patients with
malignant glioma have a dismal prognosis. The formations of aberrant tumour vasculature …
malignant glioma have a dismal prognosis. The formations of aberrant tumour vasculature …
[HTML][HTML] Interactions between anti-angiogenic therapy and immunotherapy in glioblastoma
Glioblastoma is the most aggressive brain tumor with a median survival of less than 15
months. The complex interactions between the tumor and the cells of the tumor …
months. The complex interactions between the tumor and the cells of the tumor …
[HTML][HTML] Mechanisms of glioma-associated neovascularization
ME Hardee, D Zagzag - The American journal of pathology, 2012 - Elsevier
Glioblastomas (GBMs), the most common primary brain tumor in adults, are characterized by
resistance to chemotherapy and radiotherapy. One of the defining characteristics of GBM is …
resistance to chemotherapy and radiotherapy. One of the defining characteristics of GBM is …
Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
Glioblastoma multiforme (GBM) is the most malignant brain tumor and highly resistant to
intensive combination therapies. GBM is one of the most vascularized tumors and vascular …
intensive combination therapies. GBM is one of the most vascularized tumors and vascular …